Risk-based screening is noninferior to annual screening for detecting stage ≥IIB cancers, does not reduce biopsy rates despite fewer mammograms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback